NCT05882006View on ClinicalTrials.gov

Gallstones and Risk of Inflammatory Bowel Disease

CompletedOBSERVATIONAL
Enrollment

5,035

Participants

Timeline

Start Date

May 21, 2023

Primary Completion Date

November 16, 2024

Study Completion Date

November 16, 2024

Conditions
Inflammatory Bowel Diseases
Interventions
OTHER

gallstones

fellow up if the patients have gallstones

Trial Locations (4)

518107

The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen

730000

Hepatopancreatobiliary Surgery Institute of Gansu Province, Lanzhou

Lanzhou University Second Hospital, Lanzhou

733099

Wuwei Tumor Hospital, Wuwei

All Listed Sponsors
lead

Hepatopancreatobiliary Surgery Institute of Gansu Province

OTHER

NCT05882006 - Gallstones and Risk of Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter